Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BlockMedx

BlockMedx
2017 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a medical technology designed to end the prescription opioid crisis in the United States and around the world. The company's technology is completely secure and HIPAA-compliant that uses the Ethereum blockchain for transmitting DEA controlled drug prescriptions such as prescription opioid pain relievers from physicians to pharmacies, enabling them avoid prescription forgeries, duplicates or over-prescribing.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Outcome Management (Healthcare)
Biotechnology
Primary Office
  • 221 West 6th Street
  • 3rd Floor
  • Austin, TX 78701
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BlockMedx’s full profile, request a free trial.

BlockMedx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 21-Feb-2018 Completed Generating Revenue
1. Seed Round 02-Feb-2018 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BlockMedx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MassChallenge Accelerator/Incubator 000 0000 000000 0

BlockMedx Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Brunner Founder & Chief Executive Officer
Alexander Antoniou MD Chief Medical Officer & Director, Strategy